Search

Your search keyword '"Lipids"' showing total 6 results
Start Over Descriptor "Lipids" Topic antilipemic agents Journal practice nurse
6 results on '"Lipids"'

1. Reducing cardiovascular risk: latest recommendations.

Subjects
*RISK assessment, *SERIAL publications, *ADRENOCORTICAL hormones, *ANTILIPEMIC agents, *BEHAVIOR modification, *CARDIOVASCULAR diseases, *HYPERLIPIDEMIA, *IMMUNOSUPPRESSIVE agents, *BODY mass index, *DISEASE management, *LIPIDS, *LIFE expectancy, *SMOKING, *CARDIOVASCULAR diseases risk factors, *AGE distribution, *EZETIMIBE, *PHYSICIAN practice patterns, *NURSING practice, *HEALTH behavior, *AUTOIMMUNE diseases, *STATINS (Cardiovascular agents), *DRUG prescribing, *ALCOHOLISM, *BLOOD pressure, *DIABETES
Abstract

The article focuses on the latest NICE guideline aimed at increasing the number of patients offered statins to reduce cardiovascular risk, discussing detection methods, initiating statin therapy, and optimizing treatment for both primary and secondary prevention of cardiovascular disease (CVD). It emphasizes the importance of systematic risk assessment using tools like QRISK3, baseline tests before initiating statin therapy, and considerations for treatment escalation.

Published
2024

2. New lipid targets at odds with international standards.

Author

BOSTOCK, BEVERLEY

Subjects
*DRUG therapy for hyperlipidemia, *CARDIOVASCULAR diseases risk factors, *ANTILIPEMIC agents, *LDL cholesterol, *MEDICAL protocols, *RISK assessment, *HEALTH behavior, *LIPIDS, *BEHAVIOR modification
Abstract

The article focuses on the latest NICE guideline on Cardiovascular disease (CVD) risk assessment and reduction, particularly concerning lipid management targets, which has sparked debate within the Primary Care Cardiovascular Society (PCCS) regarding its alignment with other guidelines and its potential impact on reducing cardiovascular events.

Published
2024

3. Diabetic kidney disease: diagnosis and management in primary care: Early diagnosis of diabetic renal disease (DKD) helps primary care teams to identify patients with type 2 diabetes who are at particular risk of subsequent cardiovascular disease but there is evidence of room for improvement

Author

LEWIS, DR ROBERT

Subjects
*PROTEINURIA diagnosis, *ANTILIPEMIC agents, *CARDIOVASCULAR diseases risk factors, *CREATININE, *DIABETIC nephropathies, *GLOMERULAR filtration rate, *LIPIDS, *TYPE 2 diabetes, *PRIMARY health care, *QUALITY assurance, *REFERENCE values, *RISK assessment, *ALBUMINS, *EARLY diagnosis, *ATORVASTATIN, *SODIUM-glucose cotransporters, *DISEASE complications
Abstract

The article presents an interview with Consultant Nephrologist, Robert Lewis, on diagnosis of diabetic renal disease. Topics include how has diabetic kidney disease recognised and how differ from chronic kidney disease in people without diabete; and how has proteinuria reliably detected in practice.

Published
2020

4. Prescribing for lipid modification Part 2.

Author

Sains, Katherine

Subjects
*CARDIOVASCULAR disease prevention, *FISH oils, *NIACIN, *ANTILIPEMIC agents, *CLOFIBRIC acid, *EZETIMIBE, *DRUG interactions, *DRUG monitoring, *HYPERLIPIDEMIA, *LIVER function tests, *MEDICAL office nursing, *PRIMARY health care, *WORLD Wide Web, *INFORMATION resources, *DECISION making in clinical medicine, *STATINS (Cardiovascular agents), *THERAPEUTICS
Abstract

The article presents guidelines for practice nurses in Great Britain involving prescribing for lipid modification. According to the National Institute for Health and Clinical Excellence (NICE), simvastatin is the first-line lipid-lowering treatment. Liver function should be measured to check if statins have increased liver enzymes. Alternative drugs for lipid modification are ezetimibe, fibrates, bile acid sequestrants and Omega-3 fish oils.

Published
2011

5. Prescribing for lipid modification Part 1.

Author

Sains, Katherine

Subjects
*CARDIOVASCULAR disease prevention, *ENZYME inhibitors, *ANTILIPEMIC agents, *CLOFIBRIC acid, *EZETIMIBE, *CARDIOVASCULAR diseases risk factors, *DECISION making, *HIGH density lipoproteins, *HYPERLIPIDEMIA, *LOW density lipoproteins, *TYPE 2 diabetes, *PATIENTS, *TRIGLYCERIDES, *WORLD Wide Web, *INFORMATION resources, *RELATIVE medical risk, *ACUTE coronary syndrome, *PREVENTION, *THERAPEUTICS
Abstract

The article discusses why and for whom lipid-lowering drugs should be prescribed. It explores clinical guidelines published by the British National Institute for Health and Clinical Excellence (NICE) in 2008 that address the prescribing of lipid-lowering agents. The guidance states that statins remain the first-line therapy in most cases in patients who are at high risk of a cardiovascular event, unless they are not tolerated. Lipid-lowering drugs for secondary prevention include ezetimibe, fibrates, nicotinic acid and bile acid sequestrants.

Published
2011

6. Case studies in dyslipidaemia.

Author

Bostock-Cox, Beverly

Subjects
*ANTILIPEMIC agents, *CARDIOVASCULAR disease treatment, *LIPIDS
Abstract

The author presents case studies in dyslipidaemia and the use of lipid-lowering drugs among patients at high risk of a cardiovascular event. Therapies in line with the current guidance from Great Britain's National Institute for Health and Clinical Excellence are suggested. The author stresses that decisions regarding lipid management and cardiovascular disease risk reduction must be made with the individual patient and after careful appraisal of the risks, benefits, and available alternatives.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results